Author:
Meri-Abad Marina,Blasco Cordellat Ana,Camps Herrero Carlos
Reference5 articles.
1. Pazopanib: Clinical development of a potent anti-angiogenic drug;Schutz;Crit Rev Oncol Hematol,2011
2. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial;Van der Graaf;Lancet,2012
3. SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit;Botchkareva;FASEB J Off Publ Fed Am Soc Exp Biol,2001
4. Rapid hair depigmentation in patient treated with pazopanib;Šeparović;BMJ Case Rep,2018
5. Effect of pazopanib on hair and skin hypopigmentation: A series of three patients;Sideras;J Clin Oncol,2010